[
  {
    "ts": "2025-11-24T13:00:00+00:00",
    "headline": "Iterum Therapeutics Provides Business Update",
    "summary": "DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Specialty Distributor Now Stocked: ORLYNVAH™ is now available at McKesson, which will allow certain physicians the ability to procure the product d",
    "url": "https://finance.yahoo.com/news/iterum-therapeutics-provides-business-130000200.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "08460088-f3e8-34b0-b3e1-fb7b7e63bd43",
      "content": {
        "id": "08460088-f3e8-34b0-b3e1-fb7b7e63bd43",
        "contentType": "STORY",
        "title": "Iterum Therapeutics Provides Business Update",
        "description": "",
        "summary": "DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Specialty Distributor Now Stocked: ORLYNVAH™ is now available at McKesson, which will allow certain physicians the ability to procure the product d",
        "pubDate": "2025-11-24T13:00:00Z",
        "displayTime": "2025-11-24T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/541083ed986d53eadfcc58efb6727c34",
          "originalWidth": 204,
          "originalHeight": 43,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bOXECb_i54JObPr02CZXJQ--~B/aD00Mzt3PTIwNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/541083ed986d53eadfcc58efb6727c34.cf.webp",
              "width": 204,
              "height": 43,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pndcETS3f5iegQLzonAgWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/541083ed986d53eadfcc58efb6727c34.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iterum-therapeutics-provides-business-130000200.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iterum-therapeutics-provides-business-130000200.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ITRM"
            },
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T14:15:02+00:00",
    "headline": "Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?",
    "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
    "url": "https://finance.yahoo.com/news/cardinal-health-inc-cah-soars-141502504.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "109d9923-3149-326c-a74d-c57af7db9589",
      "content": {
        "id": "109d9923-3149-326c-a74d-c57af7db9589",
        "contentType": "STORY",
        "title": "Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?",
        "description": "",
        "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
        "pubDate": "2025-11-24T14:15:02Z",
        "displayTime": "2025-11-24T14:15:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4",
          "originalWidth": 900,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/96m3P4v2KypZ_.2vXHQRKA--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4.cf.webp",
              "width": 900,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TvxSS8VO1p90iNVKrfS9eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cardinal-health-inc-cah-soars-141502504.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cardinal-health-inc-cah-soars-141502504.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            },
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T14:40:03+00:00",
    "headline": "Are Investors Undervaluing Cardinal Health (CAH) Right Now?",
    "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
    "url": "https://finance.yahoo.com/news/investors-undervaluing-cardinal-health-cah-144003680.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f1c5ac0b-e0e4-30f9-94be-8c7af246cc67",
      "content": {
        "id": "f1c5ac0b-e0e4-30f9-94be-8c7af246cc67",
        "contentType": "STORY",
        "title": "Are Investors Undervaluing Cardinal Health (CAH) Right Now?",
        "description": "",
        "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
        "pubDate": "2025-11-24T14:40:03Z",
        "displayTime": "2025-11-24T14:40:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9",
          "originalWidth": 1000,
          "originalHeight": 603,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YgRrCYuBdR1wa08RtjoPHQ--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 1000,
              "height": 603,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jAWLk_UfDMDSToA2irhEEg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-undervaluing-cardinal-health-cah-144003680.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-undervaluing-cardinal-health-cah-144003680.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T14:30:03+00:00",
    "headline": "Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?",
    "summary": "According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
    "url": "https://finance.yahoo.com/news/mckesson-mck-buy-wall-street-143003392.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "629ca230-e43c-37a5-8420-84a67cf2b748",
      "content": {
        "id": "629ca230-e43c-37a5-8420-84a67cf2b748",
        "contentType": "STORY",
        "title": "Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?",
        "description": "",
        "summary": "According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
        "pubDate": "2025-11-24T14:30:03Z",
        "displayTime": "2025-11-24T14:30:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be",
          "originalWidth": 900,
          "originalHeight": 594,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jcpSnlhnuuUas5U.67zBPQ--~B/aD01OTQ7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be.cf.webp",
              "width": 900,
              "height": 594,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gk1JxpBvTuD8ecx2ZnLlEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mckesson-mck-buy-wall-street-143003392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mckesson-mck-buy-wall-street-143003392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T17:45:04+00:00",
    "headline": "3 Reasons Growth Investors Will Love McKesson (MCK)",
    "summary": "McKesson (MCK) could produce exceptional returns because of its solid growth attributes.",
    "url": "https://finance.yahoo.com/news/3-reasons-growth-investors-love-174504808.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "18a4c910-c9e9-3325-8880-a2c88e612e97",
      "content": {
        "id": "18a4c910-c9e9-3325-8880-a2c88e612e97",
        "contentType": "STORY",
        "title": "3 Reasons Growth Investors Will Love McKesson (MCK)",
        "description": "",
        "summary": "McKesson (MCK) could produce exceptional returns because of its solid growth attributes.",
        "pubDate": "2025-11-24T17:45:04Z",
        "displayTime": "2025-11-24T17:45:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295",
          "originalWidth": 900,
          "originalHeight": 506,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/76bXBMGd31NBsgLegGAr5w--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295.cf.webp",
              "width": 900,
              "height": 506,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y3Fhh2cRRZ2a2ZMUABNaxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-growth-investors-love-174504808.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-growth-investors-love-174504808.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]